c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Cancer Research

• Publication date

  1995-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8521421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of osteoblasts in hormonal control of bone resorption—A hypothesis

  2006cited by this paper
• Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.

  1995cited by this paper
• c-fos and bone loss: a proto-oncogene regulates osteoclast lineage determination.

  1995cited by this paper
• Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes.

  1995cited by this paper
• Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation.

  1995cited by this paper
• Fos and bone cell development: lessons from a nuclear oncogene.

  1995cited by this paper
• Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment

  1994cited by this paper
• Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.

  1994cited by this paper
• c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.

  1994cited by this paper
• Two distinct target cells for v-jun mediated wound tumorigenesis.

  1994cited by this paper
• Upregulation of c‐Fos protooncogene expression in pagetic osteoclasts

  1994cited by this paper
• Gene targeting in embryonic stem cells.

  1993cited by this paper
• Osteoblasts are target cells for transformation in c-fos transgenic mice

  1993cited by this paper
• Stable murine chondrogenic cell lines derived from c‐fos‐induced cartilage tumors

  1993cited by this paper
• The tumor suppressor genes.

  1993cited by this paper
• Pleiotropic effects of a null mutation in the c-fos proto-oncogene.

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system.

  1992cited by this paper
• Bone and haematopoietic defects in mice lacking c-fos

  1992cited by this paper
• A novel target cell for c‐fos‐induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras.

  1991cited by this paper
• Gene expression during skeletal development in three osteopetrotic rat mutations. Evidence for osteoblast abnormalities.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas.

  1990cited by this paper
• Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice

  1990cited by this paper
• Identification of a chromosome 18q gene that is altered in colorectal cancers.

  1990cited by this paper
• Characterization of fos-induced osteogenic tumours and tumour-derived murine cell lines.

  1990cited by this paper
• c-fos expression induces bone tumors in transgenic mice.

  1989cited by this paper
• jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

  1989cited by this paper
• Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

  1989cited by this paper
• Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.

  1989cited by this paper
• Altering the genome by homologous recombination.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

  1989cited by this paper
• Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

  1988cited by this paper
• Detection of fos protein during osteogenesis by monoclonal antibodies

  1988cited by this paper
• Dissecting multistep tumorigenesis in transgenic mice.

  1988cited by this paper
• c-myc amplification and expression in newly established human osteosarcoma cell lines.

  1987cited by this paper
• 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region

  1987cited by this paper
• Rearrangement of the p53 gene in human osteogenic sarcomas.

  1987cited by this paper
• Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue

  1987cited by this paper
• A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.

  1987cited by this paper
• Deregulated c-fos expression interferes with normal bone development in transgenic mice

  1987cited by this paper
• Genetics of human cancer.

  1986cited by this paper
• Morphology and in vivo growth characteristics of an atypical murine proliferative osseous lesion induced in vitro.

  1986cited by this paper
• Expression of protooncogenes in murine osteosarcomas

  1986cited by this paper
• Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells.

  1984cited by this paper
• Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

  1983cited by this paper
• Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function

  1982cited by this paper
• Histogenesis and Morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice.

  1976cited by this paper
• Virus Induction of osteosarcomas in Mice

  1966cited by this paper

• Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases

  2026cites this paper
• Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell‐of‐origin model for osteoid osteoma and osteoblastoma

  2025cites this paper
• Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance

  2025cites this paper
• Identifying the Intergenic ALK Fusion LOC388942‐ALK as a Driver of Non–Small Cell Lung Cancer

  2025cites this paper
• Non-Receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling.

  2024cites this paper
• Primary Bone Tumors and Breast Cancer-Induced Bone Metastases: In Vivo Animal Models and New Alternative Approaches

  2024cites this paper
• Gene expression profile comparison of primary and pulmonary metastatic lesions in a dog with appendicular osteosarcoma and hypertrophic osteopathy

  2024cites this paper
• The generation and use of animal models of osteosarcoma in cancer research

  2023cites this paper
• A novel lncRNA GM15416 regulates osteoblast apoptosis and differentiation through the c-Fos/Fas axis and mitigates osteoporosis.

  2023cites this paper
• The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma

  2022cites this paper
• Constitutive activation of activator protein-1 as a cellular switch and its innovative role in the development of molecular targets for tongue squamous cell carcinoma treatment.

  2022cites this paper
• Osteosarcoma

  2022cites this paper
• Genomic and proteomic profiling of osteosarcoma

  2022cites this paper
• A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone Cancer.

  2022cites this paper
• Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model

  2021cites this paper
• FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53

  2021influential citation
• Identification of a 7-mRNA signature as a prognostic biomarker in pediatric osteosarcoma

  2020cites this paper
• Wnt signaling and Loxl2 promote aggressive osteosarcoma

  2020cites this paper
• Paracrine parathyroid hormone–related protein in bone: physiology and pharmacology

  2020cites this paper
• Osteosarcoma

  2020cites this paper
• Role of c-Fos in orthodontic tooth movement: an in vivo study using transgenic mice

  2020cites this paper
• MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma

  2020cites this paper
• Roles of Histone Modifications in Gastrointestinal Tumorigenesis

  2020cites this paper
• Genetic basis of ruminant headgear and rapid antler regeneration

  2019cites this paper
• Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations

  2019cites this paper
• FOS Expression in Osteoid Osteoma and Osteoblastoma

  2019cites this paper
• Murine models of osteosarcoma: A piece of the translational puzzle

  2018cites this paper
• Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib

  2018cites this paper
• Fos metamorphoses: Lessons from mutants in model organisms.

  2018cites this paper
• EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

  2018cites this paper
• Biology of Bone Sarcomas and New Therapeutic Developments

  2017cites this paper
• Molecular genetics of osteosarcoma.

  2017cites this paper
• Muscle and Bone Proliferations

  2017cites this paper
• Neuronal Activity in Ontogeny and Oncology.

  2017cites this paper
• Understanding the role of the PALB2-BRCA1 interaction in tumor suppression

  2017cites this paper
• Microenvironment Signals and Mechanisms in the Regulation of Osteosarcoma

  2017cites this paper
• MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS

  2016cites this paper
• Downregulation of connective tissue growth factor reduces migration and invasiveness of osteosarcoma cells.

  2016cites this paper
• Identification and Validation of DLG2 as a Novel Tumor Suppressor in Osteosarcoma

  2016cites this paper
• Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies

  2016cites this paper
• Osteosarcoma : searching for new treatment options

  2016cites this paper
• Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

  2016cites this paper
• Deciphering signaling networks in osteosarcoma pathobiology

  2016cites this paper
• The Functions of Histone Modification Enzymes in Cancer.

  2016cites this paper
• Selective Inhibition of Osteosarcoma Cell Functions Induced By Curcumin-Loaded Self-assembled Arginine-Rich-RGD Nanospheres

  2015cites this paper
• Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

  2015cites this paper
• A single molecule approach to investigate how AP1 transcriptional regulators find their target sites on DNA

  2015cites this paper
• MicroRNAs and Potential Targets in Osteosarcoma: Review

  2015cites this paper
• Deregulation of osteoblast differentiation in primary bone cancers

  2015cites this paper
• Modeling osteosarcoma: in vitro and in vivo approaches

  2015cites this paper
• Gene and proteomic profiling of osteosarcoma

  2015cites this paper
• Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres

  2015cites this paper
• Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS.

  2014cites this paper
• RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma

  2014cites this paper
• The role of cancer stem cells in osteosarcoma

  2014cites this paper
• Fos-dependent induction of Chk1 protects osteoblasts from replication stress

  2014cites this paper
• Role of human Desmoglein 3 in the regulation of cell morphology and motility via AP-1 and PKC dependent Ezrin activation

  2014cites this paper
• Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis

  2013cites this paper
• Activator Protein-1 Inhibition by 3-[(Dodecylthiocarbonyl)Methyl]-Glutamaride Impairs Invasion and Radiosensitizes Osteosarcoma Cells In Vitro

  2013cites this paper
• Impact de l'extinction génique de la sialoprotéine osseuse (BSP) sur la différenciation des ostéoblastes et l'ostéogenèse in vitro : développement et validation d'un bioréacteur pour la culture ostéoblastique en trois dimensions

  2013cites this paper
• Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis

  2013cites this paper
• Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression

  2013cites this paper
• Myostatin (GDF-8) Signaling in Progenitor Cells and Applications to Bone Repair : Moataz N. Elkasrawy and Mark W. Hamrick*

  2013cites this paper
• The Genetics of Osteosarcoma

  2012cites this paper
• Genetically engineered mouse models and human osteosarcoma

  2012cites this paper
• Primary Neoplasms of Bones in Mice

  2012cites this paper
• 4.9 Integrin-Activated Reactions to Metallic Implant Surfaces☆

  2011cites this paper
• Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.

  2011cites this paper
• Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis

  2011cites this paper
• CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis

  2011cites this paper
• The Molecular Pathogenesis of Osteosarcoma: A Review

  2011cites this paper
• Osteosarcomagenesis: Modeling Cancer Initiation in the Mouse

  2011cites this paper
• The Molecular Basis of Sarcoma

  2011cites this paper
• Modeling human osteosarcoma in the mouse: From bedside to bench.

  2010cites this paper
• Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human disease.

  2010cites this paper
• Molecularly targeted therapy for osteosarcoma: Where do we go from here?

  2010cites this paper
• pRb's role in cell fate, lineage commitment, and tumorigenesis

  2010cites this paper
• Genetics of Osteosarcoma

  2010influential citation
• Making gene therapy for osteosarcoma a reality

  2010cites this paper
• Signaling networks that control the lineage commitment and differentiation of bone cells.

  2009cites this paper
• Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.

  2009cites this paper
• 2. of Osteosarcoma

  2009cites this paper
• Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

  2009cites this paper
• Gene and Virotherapy Against Osteosarcoma

  2009cites this paper
• Functional genomic analyses of the impact of global hypomethylation and of tumor microenvironment in a rat model of human chondrosarcoma

  2009cites this paper
• Biotechnological Applications of Artificial Microtissues

  2009cites this paper
• The transcription factor Fos: a Janus-type regulator in health and disease.

  2009cites this paper
• Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells.

  2009cites this paper
• Infrequent amplification of JUN in hepatocellular carcinoma.

  2009cites this paper
• Root Canal Preparation Using Er:YAG Laser

  2009cites this paper
• Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.

  2008cites this paper
• Osteosarcoma Development and Stem Cell Differentiation

  2008cites this paper
• Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?

  2008cites this paper
• Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.

  2008cites this paper
• SYMPOSIUM: MOLECULAR GENETICS IN SARCOMA Osteosarcoma Development and Stem Cell Differentiation

  2008cites this paper
• Ultrasound stimulates MMP‐13 expression through p38 and JNK pathway in osteoblasts

  2008cites this paper
• Characterization of the AP-1 and NF-kappa B transcription factors in the U-87 astrocytoma cell line

  2008cites this paper
• c-Jun promotes cellular survival by suppression of PTEN

  2007cites this paper
• Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human Chondrocytes

  2007cites this paper
• Osteoclast differentiation and gene regulation.

  2007cites this paper